cyclic adp-ribose has been researched along with iloprost in 1 studies
| Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) | Studies (iloprost) | Trials (iloprost) | Recent Studies (post-2010) (iloprost) |
|---|---|---|---|---|---|
| 758 | 0 | 144 | 2,150 | 271 | 462 |
| Protein | Taxonomy | cyclic adp-ribose (IC50) | iloprost (IC50) |
|---|---|---|---|
| Prostacyclin receptor | Homo sapiens (human) | 0.0112 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, WB; Geiger, J; Li, PL; Zou, AP | 1 |
1 other study(ies) available for cyclic adp-ribose and iloprost
| Article | Year |
|---|---|
Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine; Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase; Animals; Calcium Channel Agonists; Calcium Channels; Cattle; Coronary Circulation; Coronary Vessels; Cyclic ADP-Ribose; Iloprost; Niacinamide; Phosphorus-Oxygen Lyases; Potassium Chloride; Ryanodine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |